Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Chiron in Informatics-Based Research Alliance

NEW YORK, Feb. 24 - Inpharmatica, a London-based informatics company, said today that it has begun a research collaboration with Chiron to prioritize protein targets using its PharmaCarta chemogenomics informatics platform.


Inpharmatica said it will apply the technology platform - which is used to functionally annotate full-length proteins -- to assess the druggability of proteins in genomic datasets from Chiron's oncology research program.


The agreement is Inpharmatica's second relationship involving the application of its technology outside its own internal discovery programs and the first involving druggability assessment. In January, the company expanded an existing research collaboration with Serono.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.